Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.77%507.471.0%$627.63m
DHRDanaher Corp. -1.39%258.500.7%$627.39m
MDTMedtronic Plc -1.74%80.840.6%$535.11m
ABTAbbott Laboratories -1.53%96.790.8%$533.32m
ISRGIntuitive Surgical, Inc. -0.86%187.440.8%$338.31m
SYKStryker Corp. -1.22%202.971.3%$302.85m
BSXBoston Scientific Corp. -1.47%38.761.0%$258.59m
BDXBecton, Dickinson & Co. -1.46%222.831.0%$255.81m
EWEdwards Lifesciences Corp. -1.34%82.710.4%$237.54m
ALGNAlign Technology, Inc. -1.85%207.116.4%$191.01m
DXCMDexCom, Inc. -1.90%80.541.9%$186.37m
AAgilent Technologies, Inc. -0.84%121.711.7%$182.61m
BAXBaxter International, Inc. -2.50%53.921.8%$166.39m
STESTERIS Plc (Ireland) -0.27%166.663.1%$137.19m
SWAVShockwave Medical, Inc. 0.81%278.070.0%$136.12m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.